Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00103272
Protocol Section: NCT00103272
Start Identification Module Data
Brief Title: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer
Official Title: A Phase I Study of PS-341 Velcade Bortezomib in Combination With 17-allylamino-17-demethoxygeldanamycin 17-AAG in Patients With Relapsed or Refractory Hematologic Malignancies
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: NCI-2012-01463
Secondary IDs
Secondary ID Type Domain Link
OSU 0448 None None None
NCI-6520 None None None
CDR0000409584 None None None
OSU-2004C0084 None None None
OSU-0448 None None None
U01CA076576 NIH None httpsreporternihgovquickSearchU01CA076576
Start Status Module Data
Status Verified Date: 2013-06
Overall Status: TERMINATED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Lead Sponsor: National Cancer Institute NCI
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload